Regeneron Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $1.98B | $29.35B | $2.49B |
| FY2025 | $1.99B | $31.26B | $3.12B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $1.98B | $29.35B | $2.49B |
| FY2025 | $1.99B | $31.26B | $3.12B |